Cryotherapy for Neuropathy in Children

S

South Valley University

Status

Enrolling

Conditions

Cancer

Treatments

Other: Cryotherapy (apparatus)

Study type

Interventional

Funder types

Other

Identifiers

NCT04536207
P.T.REC/012/002570

Details and patient eligibility

About

This study aimed to assess the efficacy of cryotherapy in controlling Peripheral Neuropathy in cancer children

Full description

Peripheral neuropathy is a serious condition characterized by symmetrical, distal damage to the peripheral nerves that may be caused by several classes of drugs, including chemotherapeutic agents. Chemotherapy-induced peripheral neuropathy (CIPN) is an adverse effect estimated to occur in up to 40% of patients undergoing chemotherapy, with its incidence increasing in patients being treated with multiple agents. Pharmacists play a pivotal role in the prevention and management of CIPN by recommending evidence-based pharmacologic and non pharmacologic strategies appropriate for the individual patient.Peripheral neuropathy (PN) is a systemic disease characterized by symmetrical, distal damage to the peripheral nerves that negatively impacts patient quality of life (QOL). Prolonged symptoms associated with PN can cause pain, interfere with functional ability (e.g., dressing, driving, house-work), and disrupt emotional health.

Enrollment

60 estimated patients

Sex

All

Ages

8 to 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Their age will ranging from eight to seventeen years.
  • Children participated in this study will from both sexes.
  • Children receiving chemotherapy as medical treatment protocol
  • All children have polyneuropathy caused by chemotherapy.

Exclusion criteria

  • Children with Epilepsy.
  • Children with blood clotting disorder.
  • Children have Open wounds / broken skin
  • Children with severe cardiac disease
  • Uncooperative patients.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

the study group
Experimental group
Description:
Group (A) the study group received cryotherapy
Treatment:
Other: Cryotherapy (apparatus)
the control group
No Intervention group
Description:
Group (B) the control group not received cryotherapy

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Mohammed E Ali, Ph.D student; Nehad A. Abo-Zaid, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems